The Drug Development Letter

The Drug Development Letter

Share this post

The Drug Development Letter
The Drug Development Letter
Low-dose dexamethasone in patients with newly diagnosed multiple myeloma.
Copy link
Facebook
Email
Notes
More

Low-dose dexamethasone in patients with newly…

May 24, 2024
12

Share this post

The Drug Development Letter
The Drug Development Letter
Low-dose dexamethasone in patients with newly diagnosed multiple myeloma.
Copy link
Facebook
Email
Notes
More

The NCI - ECOG E4A03 trial showed longer survival and less toxicity with low-dose dexamethasone in newly patients with multiple myeloma.

Read →
Comments
User's avatar
© 2025 Vinay Prasad
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More